TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $910,502 | +16.4% | 58,856 | +18.2% | 0.17% | +17.6% |
| Q2 2023 | $782,327 | +57.8% | 49,798 | +65.5% | 0.15% | +45.1% |
| Q1 2023 | $495,850 | +5.6% | 30,088 | 0.0% | 0.10% | +3.0% |
| Q4 2022 | $469,373 | +20.4% | 30,088 | 0.0% | 0.10% | +2.1% |
| Q3 2022 | $390,000 | -36.7% | 30,088 | -31.5% | 0.10% | -28.1% |
| Q2 2022 | $616,000 | +211.1% | 43,898 | +217.9% | 0.14% | +206.8% |
| Q1 2022 | $198,000 | – | 13,810 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |